GlaxoSmithKline's Cervarix Drug Approved by EU

by VR Sreeraman on  September 24, 2007 at 8:18 PM Drug News
RSS Email Print This Page Comment
British pharmaceutical giant GlaxoSmithKline said Monday that the European Union has allowed it to market Cervarix -- a drug used to treat cervical cancer.
GlaxoSmithKline's Cervarix Drug Approved by EU
GlaxoSmithKline's Cervarix Drug Approved by EU
Advertisement

"The decision (by the European Commission) to approve Cervarix for the European Union represents a great step forward for European women," GSK chief executive JP Garnier said in a statement.

Advertisement
"Physicians across Europe will now have access to this important vaccine to help protect women against cervical cancer, the second most common cancer in women," he added.

The EU consists of 27 nations, including Britain, France and Germany.

Source: AFP
SRM /J
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive